IP Library Granted Patent US 10,335,515
Granted Patent B2
US 10,335,515 · App. 14/918,229 · Granted Jul 2, 2019

Hydrogel precursors having nanoparticles

Inventors: Michael Detamore (Lawrence, KS); Emily Beck (Lawrence, KS); Stevin Gehrke (Lawrence, KS); Cory Berkland (Lawrence, KS)
Assignee: The University of Kansas
A61L27/48A61L27/20A61L27/383A61L27/3817A61L27/3834A61L27/50A61L27/52A61L27/54A61L2430/06A61L2430/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,335,515
App. No.
14/918,229
Granted
Jul 2, 2019
Kind
B2
Abstract

An implantable hydrogel precursor composition can include: a cross-linkable polymer matrix that is biocompatible; and a plurality of polymer particles in the cross-linkable polymer matrix. The cross-linkable polymer matrix can include a cross-linkable hyaluronic acid polymer that has cross-linkable functional groups. The hyaluronic acid polymer can be a methacrylated hyaluronic acid polymer. The methacrylated hyaluronic acid polymer can have a molecular weight from about 500 kDa to about 1.8 MDa. The polymer particles can include a cross-linked hyaluronic acid. The cross-linkable polymer matrix having the polymer particles has a yield stress. The cross-linkable polymer matrix having the polymer particles has shape retention at physiological temperatures. The composition can include live cells in the cross-linkable polymer matrix. The composition can include a biologically active agent in the cross-linkable polymer matrix.

Claims (31)

1. A shape retaining implantable hydrogel precursor composition comprising:

a cross-linkable hyaluronic acid polymer having a cross-linkable functional group forming a cross-linkable polymer matrix that is biocompatible;

a photoinitiator; and

a plurality of polymer nanoparticles in the cross-linkable polymer matrix, wherein the polymer nanoparticles are cross-linked hyaluronic acid,

wherein:

the cross-linkable hyaluronic acid polymer is present from about 2% to about 10%;

the polymer nanoparticles are present from about 10% to about 40%; and

the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles is a non-flowable gel or paste and has a yield stress in Pa at zero shear rate s −1 , wherein:

the cross-linkable functional group is cross-linkable with the photoinitiator, and

the shape retaining implantable hydrogel precursor composition has a shape and shape retention thereof.

2. The composition of claim 1 , wherein the hyaluronic acid polymer is a methacrylated hyaluronic acid polymer.

3. The composition of claim 2 , wherein the methacrylated hyaluronic acid polymer has a molecular weight from about 500 kDa to about 1.8 MDa.

4. The composition of claim 1 , wherein the polymer nanoparticles have a molecular weight of about 10 kDa to about 20 kDa.

5. The composition of claim 1 , wherein the polymer nanoparticles have a particle size of about 10 nm to about 500 nm.

6. The composition of claim 1 , wherein:

the polymer particles are present from about 10% to about 30%.

7. The composition of claim 1 , wherein the ratio of cross-linkable hyaluronic acid polymer to polymer nanoparticles is from 1:15 to about 2:1.

8. The composition of claim 1 , wherein the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles has shape memory at physiological temperatures.

9. The composition of claim 1 , further comprising live cells in the cross-linkable polymer matrix.

10. The composition of claim 1 , further comprising a biologically active agent in the cross-linkable polymer matrix.

11. The composition of claim 6 , wherein the polymer nanoparticles are present from about 10% to about 20%.

12. The composition of claim 1 , wherein the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles has a non-zero shear stress at a shear rate below 1 s −1 .

13. The composition of claim 11 , wherein the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles has a yield stress of at least about 400 Pa to about 800 Pa.

14. The composition of claim 11 , wherein the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles has a shear stress of about 500 Pa to about 1000 Pa at 1 s −1 shear rate.

15. The composition of claim 11 , wherein the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles has the following storage modulus:

about 400 Pa to about 1100 Pa at an initial phase;

about 10 Pa to about 400 Pa at a disruption phase; and

about 500 Pa to about 1200 Pa at a recovery phase.

16. The composition of claim 1 , wherein the cross-linkable hyaluronic acid polymer matrix having the polymer nanoparticles is an unflowable paste having a defined shape below the yield stress.

17. The composition of claim 1 , further comprising particles of decellularized cartilage and/or cross-linkable decellularized cartilage in the cross-linkable polymer matrix.

18. The composition of claim 2 , percent methacrylation of the methacrylated hyaluronic acid polymer is 5%-40%.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 27, 2017
From: UNIVERSITY OF KANSAS LAWRENCE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044961/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2015
From: DETAMORE, MICHAEL; GEHRKE, STEVIN; BECK, EMILY; BERKLAND, CORY
To: THE UNIVERSITY OF KANSAS
Reel/Frame 037010/0957 →
Continuity (4)
Continuation In Part PCTUS2014057498 · Sep 25, 2014
Provisional Application 62066164 · Oct 20, 2014
Provisional Application 61882397 · Sep 25, 2013
Related Publication 20160038643A1 · Feb 11, 2016